Hematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem CellsTransplantation ConditioningStem CellsBone Marrow TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantationMyeloid CellsHematologic NeoplasmsTreatment OutcomeStem Cell NicheHistocompatibility TestingImmunocompromised HostTissue DonorsHematopoietic Stem Cell MobilizationCell DifferentiationPeripheral Blood Stem Cell TransplantationHematopoiesisRetrospective StudiesHepatic Veno-Occlusive DiseaseImmunosuppressive AgentsMultiple MyelomaRecurrenceHodgkin DiseaseAdult Stem CellsAntigens, CD34LeukemiaKidney TransplantationPancytopeniaMice, Inbred C57BLCell LineageTransplantation ChimeraBone Marrow CellsFlow CytometryGraft SurvivalAnemia, AplasticBone MarrowSurvival AnalysisEmbryonic Stem CellsTransplantsCytomegalovirus InfectionsColony-Forming Units AssayFetal BloodCells, CulturedHLA AntigensAntifungal AgentsCell ProliferationGraft RejectionOpportunistic InfectionsFollow-Up StudiesPluripotent Stem CellsTime FactorsStromal CellsMycosesCell CountAspergillosisMesenchymal Stem Cell TransplantationHistocompatibilityNeural Stem CellsCytomegalovirusInduced Pluripotent Stem CellsSignal TransductionHeart TransplantationRoseolovirus InfectionsWhole-Body IrradiationMultipotent Stem CellsCombined Modality TherapyGene Expression RegulationBlood Transfusion, AutologousMesenchymal Stromal CellsStem Cell FactorImmunosuppressionCyclosporineLung TransplantationBusulfanAntiviral AgentsSurvival RateHematologic DiseasesPostoperative ComplicationsFatal OutcomeLeukemia, Myeloid, AcuteSalvage TherapyCord Blood Stem Cell TransplantationGanciclovirBK VirusAcute DiseaseRisk FactorsMelphalanHerpesvirus 6, HumanFetal Tissue TransplantationGranulocyte Colony-Stimulating FactorAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesPolyomavirus InfectionsCell SurvivalProspective StudiesTissue and Organ Procurement